01 5Merck Canada Inc.
01 12120619
02 12478094
03 12580367
04 12632078
05 12671976
01 5Vorinostat
01 5Capsule
01 12012-10-05
02 32023-03-04
03 12026-05-16
Patent Expiration Date : 2012-10-05
Date Granted : 2006-11-21
Brand Name : ZOLINZA
Patent Number : 2120619
Filing Date : 1992-10-05
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-10-05
Date Granted : 2006-11-21
Patent Expiration Date : 2023-03-04
Date Granted : 2010-11-23
Brand Name : ZOLINZA
Patent Number : 2478094
Filing Date : 2003-03-04
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-04
Date Granted : 2010-11-23
Patent Expiration Date : 2023-03-04
Date Granted : 2012-08-14
Brand Name : ZOLINZA
Patent Number : 2632078
Filing Date : 2003-03-04
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-04
Date Granted : 2012-08-14
Patent Expiration Date : 2026-05-16
Date Granted : 2012-08-21
Brand Name : ZOLINZA
Patent Number : 2580367
Filing Date : 2006-05-16
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-05-16
Date Granted : 2012-08-21
Patent Expiration Date : 2023-03-04
Date Granted : 2016-05-10
Brand Name : ZOLINZA
Patent Number : 2671976
Filing Date : 2003-03-04
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-04
Date Granted : 2016-05-10
